Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications
Pharmaceutics · 09.06.2026 · 18 (6) · 711
DOI: 10.3390/pharmaceutics18060711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.06.2026. Verfasst von Francisca Acevedo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Millennium Nucleus Bioproducts, Genomics and Environmental Microbiology (BioGEM), Avenida España 1680, Valparaíso 2390123, Chile. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo.
Abstract (Originalsprache)
Background/Objectives: Wound infections represent a major clinical challenge due to their polymicrobial nature, biofilm formation, and increasing antimicrobial resistance, which compromise conventional treatments. This study aimed to develop and evaluate ligand-stabilized silver nanoparticles (AgNPs) with improved antimicrobial activity and cytocompatibility, and to investigate their incorporation into electrospun nanofibers for wound management.
Methods
Four AgNP formulations stabilized with citrate, cysteine, ketorolac, and diclofenac were synthesized via chemical reduction. Physicochemical characterization included surface plasmon resonance and zeta potential measurements. Antimicrobial activity was assessed through minimum inhibitory concentration (MIC) and bactericidal assays against Gram-positive, Gram-negative, and fungal strains. Toxicity was evaluated using the HET-CAM assay, while cytocompatibility was determined in fibroblasts, MG-63 cells, and mesenchymal stem cells. Diclofenac-stabilized AgNPs were incorporated into electrospun PCL/PEO nanofibers to generate a functional nanocomposite system.
Results
All AgNPs exhibited a characteristic SPR at ~400 nm and high colloidal stability. Diclofenac-stabilized AgNPs (dc-AgNPs) showed the highest antimicrobial activity, with MIC values of 18.8 mg/L against Staphylococcus aureus and Pseudomonas aeruginosa, and 4.7 mg/L against Candida albicans, along with strong bactericidal effects. HET-CAM assays indicated negligible irritation at concentrations up to 75 mg/L. Cytocompatibility results revealed a dose-dependent response, with fibroblasts being more sensitive. Electrospun nanofibers loaded with dc-AgNPs achieved a 2.6 log reduction against Streptococcus mutans and moderate reductions (0.4–0.7 log) against other pathogens.
Conclusions
Ligand engineering critically influences the antimicrobial efficacy and biocompatibility of AgNPs. The incorporation of dc-AgNPs into electrospun nanofibers represents a promising approach for treating biofilm-associated wound infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Millennium Nucleus Bioproducts, Genomics and Environmental Microbiology (BioGEM), Avenida España 1680, Valparaíso 2390123, Chile.
- Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Avenida Francisco Salazar 1145, Temuco 4780000, Chile.
- Center of Excellence in Translational Medicine (CEMT), and Scientific and Technological Bioresource Nucleus (BIOREN), Faculty of Medicine, Universidad de La Frontera, Avenida Francisco Salazar 1145, Temuco 4780000, Chil…
- Center for Soft Matter Research, SMAT-C, Faculty of Chemistry and Biology, Universidad de Santiago de Chile, Avenida Ecuador, Estación Central, Santiago 9170124, Chile.
- Department of Integral Adult Dentistry, Faculty of Dentistry, Universidad de La Frontera, P.O. Box 54-D, Temuco 4811230, Chile.
- Doctoral Program in Sciences, Mention in Applied Cell and Molecular Biology, Universidad de La Frontera, Avenida Francisco Salazar 1145, Temuco 4780000, Chile.
ORCID-Profile: Francisca Acevedo, Manuel Azocar, Eulàlia Sans-Serramitjana, Jeyson Hermosilla, Felipe Gálvez-Jirón, Dayaimi Gonzalez, Gabriela Guajardo
Förderung
- Agencia Nacional de Investigación y Desarrollo
Zitieren
APA
Acevedo, F., Azocar, M., Sans-Serramitjana, E., Hermosilla, J., Gálvez-Jirón, F., Bravo, D., Gonzalez, D., Guajardo, G., Guajardo, C., & Navia, R. (2026). Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications. Pharmaceutics, 18(6), 711. https://doi.org/10.3390/pharmaceutics18060711
Vancouver
Acevedo F, Azocar M, Sans-Serramitjana E, Hermosilla J, Gálvez-Jirón F, Bravo D, et al. Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications. Pharmaceutics. 2026;18(6):711. doi:10.3390/pharmaceutics18060711
BibTeX
@article{Acevedo2026,
author = {Acevedo, Francisca and Azocar, Manuel and Sans-Serramitjana, Eulàlia and Hermosilla, Jeyson and Gálvez-Jirón, Felipe and Bravo, Denisse and Gonzalez, Dayaimi and Guajardo, Gabriela and Guajardo, Cristóbal and Navia, Rodrigo},
title = {Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {6},
pages = {711},
doi = {10.3390/pharmaceutics18060711}
}
EUVIMED